Konrad E. Tomaszewski
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- COVID-19 Clinical Research Studies
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antifungal resistance and susceptibility 4
-
- Metabolism and Genetic Disorders 5
- Co-authors
- Nolan Wood (4 shared papers)Ronald L. Melnick (7 shared papers)Bharat Damle (2 shared papers)David R. Luke (2 shared papers)Haran T. Schlamm (1 shared paper)Peter F. Troke (1 shared paper)Keith Tan (1 shared paper)Deepak Agarwal (1 shared paper)
- Journals
- Carcinogenesis (2 papers)Journal of Pharmaceutical Sciences (1 paper)Toxicology and Industrial Health (1 paper)Journal of the International AIDS Society (1 paper)Toxicology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Konrad E. Tomaszewski
17 papers receiving 728 citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 342
- Pharmacology 90
- Pharmaceutical Science 58
- Clinical Biochemistry 51
- Ophthalmology 62
Countries citing papers authored by Konrad E. Tomaszewski
This map shows the geographic impact of Konrad E. Tomaszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad E. Tomaszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad E. Tomaszewski more than expected).
Fields of papers citing papers by Konrad E. Tomaszewski
This network shows the impact of papers produced by Konrad E. Tomaszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad E. Tomaszewski. The network helps show where Konrad E. Tomaszewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Konrad E. Tomaszewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 198 | |
| 2 | 2010 | 164 | |
| 3 | 1989 | 101 | |
| 4 | 1986 | 65 | |
| 5 | 2008 | 42 | |
| 6 | 2011 | 40 | |
| 7 | 2014 | 23 | |
| 8 | 1990 | 23 | |
| 9 | 1987 | 23 | |
| 10 | 1987 | 19 | |
| 11 | 1988 | 17 | |
| 12 | 1994 | 10 | |
| 13 | 2010 | 7 | |
| 14 | 1993 | 7 | |
| 15 | 1987 | 6 | |
| 16 | 1991 | 5 | |
| 17 | 1993 | 2 | |
| 18 | 2008 | 1 |
About Konrad E. Tomaszewski
Konrad E. Tomaszewski is a scholar working on Infectious Diseases, Clinical Biochemistry, Molecular Biology, Pharmacology and Pharmacology, having authored 18 papers that have together received 753 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (5 papers), Antifungal resistance and susceptibility (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Legionella and Acanthamoeba research (2 papers) and Ocular Infections and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (342 citations), Pharmacology (90 citations), Pharmaceutical Science (58 citations), Clinical Biochemistry (51 citations) and Ophthalmology (62 citations). Konrad E. Tomaszewski has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Nolan Wood, Ronald L. Melnick, Bharat Damle, David R. Luke, Haran T. Schlamm, Peter F. Troke, Keith Tan, Deepak Agarwal, Michael J. Olson and James A. Popp. Their work appears in journals such as Carcinogenesis, Journal of Pharmaceutical Sciences, Toxicology and Industrial Health, Journal of the International AIDS Society and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.